NASDAQ:GELS - Nasdaq - AU0000218109 - Common Stock - Currency: USD
NASDAQ:GELS (3/7/2025, 8:00:01 PM)
1.2799
-0.05 (-3.77%)
The current stock price of GELS is 1.2799 USD. In the past month the price decreased by -43.62%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
LLY | ELI LILLY & CO | 66.89 | 824.51B | ||
JNJ | JOHNSON & JOHNSON | 16.69 | 401.33B | ||
NVO | NOVO-NORDISK A/S-SPONS ADR | 26.18 | 386.95B | ||
AZN | ASTRAZENECA PLC-SPONS ADR | 21.41 | 240.28B | ||
MRK | MERCK & CO. INC. | 12.39 | 239.09B | ||
NVS | NOVARTIS AG-SPONSORED ADR | 14.56 | 228.26B | ||
PFE | PFIZER INC | 8.59 | 151.49B | ||
SNY | SANOFI-ADR | 14.24 | 148.55B | ||
BMY | BRISTOL-MYERS SQUIBB CO | 53.59 | 123.97B | ||
GSK | GSK PLC-SPON ADR | 8.29 | 81.62B | ||
ZTS | ZOETIS INC | 28.78 | 76.29B | ||
TAK | TAKEDA PHARMACEUTIC-SP ADR | 33.71 | 47.88B |
Gelteq Ltd is a AU-based company operating in Pharmaceuticals industry. The company is headquartered in Melbourne, Victoria. The company went IPO on 2024-10-29. Gelteq Limited is an Australia-based clinical and science-based company. The firm is focused on developing and commercializing white-label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. The firm offers a complete end-to-end service for the development of new products and the conversion of existing products and formulations into gels. Its product suite consists of multiple products that sit within five core verticals - for pets, sports, pharmaceuticals (pharma), over-the-counter (OTC) and nutraceuticals. The Company’s delivery system provides pharma and nutraceutical enhancements throughout every stage of ingestion in both animals and humans, addressing the complete experience from the point of ingestion to final absorption. The firm also offers a highly versatile portfolio of pre-tested and market-ready proprietary formulations that can be white-labelled.
GELTEQ LTD
Level 4, 100 Albert Road
Melbourne VICTORIA AU
Employees: 0
Company Website: https://www.gelteq.com
Phone: 61390873990
The current stock price of GELS is 1.2799 USD. The price decreased by -3.77% in the last trading session.
The exchange symbol of GELTEQ LTD is GELS and it is listed on the Nasdaq exchange.
GELS stock is listed on the Nasdaq exchange.
GELTEQ LTD (GELS) has a market capitalization of 12.08M USD. This makes GELS a Nano Cap stock.
GELTEQ LTD (GELS) currently has 0 employees.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
GELS does not pay a dividend.
GELTEQ LTD (GELS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.24).
The outstanding short interest for GELTEQ LTD (GELS) is 0.52% of its float. Check the ownership tab for more information on the GELS short interest.
ChartMill assigns a fundamental rating of 1 / 10 to GELS. GELS has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months GELS reported a non-GAAP Earnings per Share(EPS) of -0.24. The EPS decreased by -1.13% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -17.08% | ||
ROE | -23.47% | ||
Debt/Equity | 0.12 |